TEDENZI

Serial Number 90754819
606

Registration Progress

Application Filed
Jun 4, 2021
Under Examination
May 24, 2022
Approved for Publication
Mar 29, 2022
Published for Opposition
Mar 29, 2022
Registered

Trademark Image

TEDENZI

Basic Information

Serial Number
90754819
Filing Date
June 4, 2021
Published for Opposition
March 29, 2022
Abandonment Date
December 26, 2022
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 26, 2022
Classes
005

Rights Holder

Coherus BioSciences, Inc.

03
Address
333 Twin Dolphin Dr, Suite 600
Redwood City, CA 94065

Ownership History

Coherus BioSciences, Inc.

Original Applicant
03
Redwood City, CA

Coherus BioSciences, Inc.

Owner at Publication
03
Redwood City, CA

Legal Representation

Attorney
Anthony Malutta

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

10 events
Date Code Type Description Documents
Dec 27, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Dec 26, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
May 24, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 29, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 29, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 9, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 23, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 22, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 26, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 8, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the prevention and treatment of auto-immune, inflammatory, hematological, hepatological, cardiovascular, pulmonary, central nervous system, neurological system, pain, inflammation, dermatologic, gastro-intestinal, hormonal, psychiatric, infectious-related, viral, metabolic, oncologic, ophthalmic, respiratory, digital ulcers, musculo-skeletal, genitourinary, sexual dysfunction, and cerebrovascular diseases and disorders; vaccines; anxiolytics; anti-allergics; anti-infectives

Classification

International Classes
005